Why the study?
Does long-term estrogen replacement treatment improve cardioprotection from ischemic preconditioning in isolated hearts of ovariectomized rats?
Does long-term estrogen replacement treatment improve cardioprotection from ischemic preconditioning in isolated hearts of ovariectomized rats?
Long-term estrogen replacement does not alter myocardial ischemia-reperfusion injury or the cardioprotective effects of ischemic preconditioning in ovariectomized rat hearts.
Long-term estrogen replacement confers no protection against ischemia-reperfusion or preconditioning in rat hearts; leaves open clinical translation.
In the present study, we tested the effects of long-term estrogen replacement treatment on myocardial ischemia-reperfusion injury and on the cardioprotection of ischemic preconditioning in isolated hearts from ovariectomized rats. Ovariectomized rats were treated with 17beta-estradiol (30 micro g/kg/d, s.c.) for 12 weeks. Isolated rat hearts were perfused in the Langendorff mode. Heart rate, coronary flow, left ventricular pressure and its first derivative (+/-LVdp/dtmax) were recorded. Fifteen-min global ischemia and 30-min reperfusion caused a significant decrease of cardiac mechanical function, which were not affected by ovariectomy or estrogen replacement treatment. The isolated hearts in all groups could be preconditioned, and the cardioprotection afforded by preconditioning in the sham-operated rats was greater compared with ovariectomized rats with or without estrogen treatment. These results suggest that long-term estrogen replacement treatment exerts no effect on the inhibition of mechanical function after ischemia-reperfusion, and this study also suggests that estrogen does not affect ischemic preconditioning in isolated hearts of ovariectomized rats.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: